$0.79
▼ $-0.11
(-11.78%)
Vol 801K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$467K
ROE
-233.1%
Margin
-709901.9%
D/E
36.08
Beta
1.47
52W
$1–$6413
Wall Street Consensus
8 analysts · Jul 20242
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Earnings
Beat rate: 25.0%
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Sep 2025 | — | $-73.15 | — |
| Dec 2023 | $-274872066.43 | $-332852799.99 | $-57980733.56 |
| Sep 2023 | $-73581984.00 | $-433919999.99 | $-360338015.99 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -233.1% | -276.9% | -233.1% | -233.1% | -233.1% | -233.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -725681.0% | -45955.3% | -208583.1% | -208583.1% | -208583.1% | -709901.8% |
| Gross Margin | -1.0% | -916.5% | -4383.7% | -4383.7% | -4383.7% | -1135.0% |
| D/E Ratio | 36.08 | 18.73 | 36.08 | 36.08 | 36.08 | 36.08 |
| Current Ratio | 0.02 | 0.08 | 0.02 | 0.02 | 0.02 | 0.02 |
Key Ratios
ROA (TTM)
-156.7%
P/S (TTM)
78.46
P/B
0.3
EPS (TTM)
$-13217.70
CF/Share
$-201.51
Rev Growth 3Y
+6.8%
52W High
$6412.75
52W Low
$1.05
$1.05
52-Week Range
$6412.75
How does ADTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ADTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
78.5
▲
511%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.3
▼
88%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ADTX profitability vs Biotechnology peers
ROE
-233.1%
▼
246%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-709901.9%
▼
247468%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
-1135.0%
▼
1544%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-156.7%
▼
235%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ADTX financial health vs Biotechnology peers
D/E ratio
36.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.0
▼
100%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲
52%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ADTX fundamentals radar
ADTX
Peer median
Industry
ADTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ADTX vs peers: key metrics
Latest News
No related news yet